Gliomas, glioneural and neuronal tumours_ CNS 5 WHO 2021 Flashcards
What types of tumours are included in the tumour group “Adult-type diffuse gliomas”?
- Astrocytoma, IDH-mutant
- Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
- Glioblastoma, IDH-wildtype
What types of tumours are included in the tumour group “Paediatric-type diffuse low-grade gliomas”?
- Diffuse astrocytoma, MYB- or MYBL1-altered
- Angiocentric glioma
- Polymorphous low-grade neuroepithelial tumour of the young
- Diffuse low-grade glioma, MAPK pathway-altered
What types of tumours are included in the tumour group “Paediatric-type diffuse high-grade gliomas”?
Diffuse midline glioma, H3 K27-altered
- Diffuse hemispheric glioma, H3 G34-mutant
- Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
- Infant-type hemispheric glioma
What types of tumours are included in the tumour group “Circumscribed astrocytic gliomas”?
- Pilocytic astrocytoma
- High-grade astrocytoma with piloid features
- Pleomorphic xanthoastrocytoma
- Subependymal giant cell astrocytoma
- Chordoid glioma
- Astroblastoma, MN1-altered
What types of tumours are included in the tumour group “Glioneuronal and neuronal tumours”?
- Ganglioglioma
- Desmoplastic infantile ganglioglioma/desmoplastic infantile astrocytoma
- Dysembryoplastic neuroepithelial tumour DNET
- Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters
- Papillary glioneuronal tumour
- Rosette-forming glioneuronal tumour
- Myxoid glioneuronal tumour
- Diffuse leptomeningeal glioneuronal tumour
- Gangliocytoma
- Multinodular and vacuolating neuronal tumour
- Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)
- Central neurocytoma
- Extraventricular neurocytoma
- Cerebellar liponeurocytoma
What types of tumours are included in the tumour group “Ependymomas”?
- Supratentorial ependymoma
- Supratentorial ependymoma (ZFTA or YAP1 fusion-positive)
- Posterior fossa ependymoma
- Posterior fossa ependymoma (PFA or PFB group)
- Pinal ependymoma
- Spinal ependymoma, MYCN amplified
- Myxopapillary ependymoma
- Subependymoma
What does ATRX mutation stand for?
Alpha-thalassemia/mental retardation syndrome X
What does “CDKN2A/B” stand for?
Cyclin-dependent kinase inhibitor 2A/B
What does “EGFR” stand for?
Epidermal growth factor receptor
What does “H3 G34” stand for?
Histone H3 3 G34
What does “H3 K27M” stand for?
Histone H3 K27M
In what glioma type/s is “ZFTA fusions” clinically relevant?
- Present in some supratentorial ependymomas (ZFTA: previously named RELA fusions)
What does “IDH1/2” mutation stand for?
Isocitrate dehydrogenase
What does “MAPK” stand for?
Mitogen-activated protein kinase pathway
What does “MGMT” stand for?
methylation O6-methylguanine DNA methyltransferase
In what glioma type/s is “Gain of chromosome 7/loss of chromosome 10 (+ 7/ − 10)” clinically relevant?
- Common in glioblastoma IDH-wildtype CNS WHO grade 4
What does “TERTp” stand for?
Telomerase reverse transcriptase promotor
What does “YAP1 “ stand for?
Yes-associated protein 1
what does “ZFTA” stand for?
Zinc finger translocation associated
In what glioma type/s is “Loss of chromosome 1p and 19q (loss of heterozygosity) (1p/19q codeletion)” clinically relevant?
- Prerequisite for the diagnosis of oligodendroglioma
In what glioma type/s is “H3 K27M mutation” clinically relevant?
- One of the criteria of diffuse midline glioma, H3 K27M altered
- May occur in other gliomas not located in the midline (pilocytic astrocytoma and ependymoma)
In what glioma type/s is “H3 G34 mutation
Histone H3 3 G34” clinically relevant?
- Present in hemispheric diffuse glioma, IDH-wildtype, predominantly in children and young adults, poor prognosis
In what glioma type/s is “EGFR-mutations” clinically relevant?
- Common in glioblastoma, IDH-wildtype CNS WHO grade 4
- If present in astrocytoma, IDH-wildtype CNS WHO grades 2 or 3, it is consistent with glioblastoma, IDH-wildtype CNS WHO grade 4
In what glioma type/s is “EGFR-mutations” clinically relevant?
- Most common is EGFRvIII, frequently present in glioblastoma, IDH-wildtype CNS WHO grade 4
In what glioma type/s is “H3 G34 mutation” clinically relevant?
- Present in hemispheric diffuse glioma, IDH-wildtype, predominantly in children and young adults, poor prognosis
In what glioma type/s is “YAP1 fusions” clinically relevant?
- Present in some supratentorial ependymomas, especially in paediatric tumours
In what glioma type/s is “TP53 mutation” clinically relevant?
- Present in most astrocytoma IDH-mutant, rare in oligodendrogliomas
In what glioma type/s is “TERTp mutation” clinically relevant?
- Present in most oligodendroglioma
- If present in diffuse astrocytoma, IDH-wildtype CNS WHO grades 2 and 3 (i.e. without the histopathological hallmarks of glioblastoma (necrosis and/or microvascular proliferation)), it is consistent with glioblastoma IDH-wildtype CNS WHO grade 4
In what glioma type/s is “MYB- or MYBL1-altered” clinically relevant?
- Alterations typical for a paediatric low-grade glioma
In what glioma type/s is “MGMT promotor methylation” clinically relevant?
- DNA repair enzyme, methylation predicts good response to alkylating agents such as temozolomide in glioblastoma, IDH-wildtype
In what glioma type/s is “MAPK” clinically relevant?
- Alterations typical for paediatric-type diffuse low-grade gliomas
In what glioma type/s is “KIAA1549-BRAF gene fusion” clinically relevant?
Frequently found in pilocytic astrocytoma, also in diffuse leptomeningeal glioneuronal tumour, pilomyxoid astrocytoma and gangliogliomae
In what glioma type/s is “IDH1/2” clinically relevant?
- Frequently mutated in diffuse gliomas (astrocytomas and oligodendrogliomas) and is associated with better prognosis than IDH-wildtype gliomas
In what glioma type/s is “H3 K27M mutation” clinically relevant?
- One of the criteria of diffuse midline glioma, H3 K27M altered
- May occur in other gliomas not located in the midline (pilocytic astrocytoma and ependymoma)
In what glioma type/s is “EGFR gene amplification” clinically relevant?
- Common in glioblastoma, IDH-wildtype CNS WHO grade 4
- If present in astrocytoma, IDH-wildtype CNS WHO grades 2 or 3, it is consistent with glioblastoma, IDH-wildtype CNS WHO grade 4
In what glioma type/s is “CDKN2A/B homozygous deletion” clinically relevant?
- Present in astrocytoma, IDH-mutant indicates poor prognosis and despite lack of microvascular proliferation and or necrosis they are grade 4.
In what glioma type/s is “BRAF V600 mutation” clinically relevant?
- Frequently present in pleomorphic xanthoastrocytoma, also in ganglioglioma and epitheloid glioblastoma
In what glioma type/s is “ATRX mutation” clinically relevant?
- Common in astrocytoma, IDH-mutant (not in oligodendroglioma) and diffuse hemispheric glioma, H3 G34–mutant
What more is needed for a IDH1 wt diffuse glioma to be named “Glioblastoma IDH wt CNS WHO gr4”?
One or more of the following:
* microvascular proliferation
* Necrosis
* TERTp mutation
* EGFR gene amplification
*+7/-10
What more is needed for a diffuse glioma, IDH1 mutant to be a Oligodendroglioma IDH mutant (XXXXX) CNS WHO grade 2/3?
ATRX retained and 1p/19 codeletion.
What more is needed for a diffuse glioma, IDH1 mutant to be called “Astrocytoma IDH-mutant CNS WHO grade 2/3”?
ATRX mutation, P53 mutation
What homozygous deletion can be found in an otherwise “Astrocytoma IDH mutant grade 2/3” that will make it an “Astrocytoma IDH mutant CNS WHO grade 4”?
CDKN 2A/B
What is a diffuse glioma, IDH1 mutant, ATRX mutant/P53 mutant with microvascular proliferation and/or necrosis called?
Astrocytoma IDH mutant CNS WHO grade 4.
WHO 2016 called “Glioblastoma, IDH mutant WHO grade IV” is now called
Astrocytoma, IDH mutant, CNS WHO grade 4.
WHO 2016 called “Diffuse astrocytoma, IDH-wildtype, WHO grade II*” is now called
Glioblastoma, IDH-wildtype, CNS WHO grade 4
WHO 2016 called “Diffuse astrocytoma, IDH-wildtype, WHO grade II*” is now called
Glioblastoma, IDH-wildtype, CNS WHO grade 4
WHO 2016 called “Anaplastic astrocytoma, IDH-wildtype, WHO grade III*” is now called
Glioblastoma, IDH-wildtype, CNS WHO grade 4
WHO 2016 called “Anaplastic oligodendroglioma, IDH-mutant and 1p/19q codeleted WHO grade III” is now called
Oligodendroglioma, IDH-mutant and 1p/19q codeleted, CNS WHO grade 3
WHO 2016 called “Anaplastic astrocytoma, IDH-mutant, WHO grade III” is now called
Astrocytoma, IDH-mutant, CNS WHO grade 3
Name (A-F) the new major groups of gliomas, glioneuronal and neuronal tumors
A. Adult type diffuse gliomas
B. Pediatric type diffuse low grade gliomas
C. Pediatric type diffuse high grade gliomas
D. circumscribed astrocytic gliomas
E. Glioneuronal and neuronal tumors
F. Ependymomas
What is the most common adult intraaxial tumor?
Glioma, about 6/100.000
How many % of gliomas recur away from original site?
10%
Name the 3 main ways a glioma may spread
- through white matter
- Through CSF
- Rarely they spread systemically.
Name 5 ways gliomas can spread through white matter
- corpus callosum
- cerebral peduncles
- internal capsule
- uncinate fasciculus
- interthalamic adhesion
What type of spreading of glioma come from way through corpus callosum?
- through genu or body CC - bilateral frontal lobe involvement (butterfly glioma)
- through splenium of CC - bilateral parietal or occipital lobes
What type of spreading of glioma come from way through cerebral peduncles?
midbrain involvement
What type of spreading of glioma come from way through internal capsule?
encroachment of basal ganglion tumors into centrum ovale
What type of spreading of glioma come from way through uncinate fasciculus?
simultaneous temporal and frontal tumours
What type of spreading of glioma come from way through interthalamic adhesion?
bilateral thalamic gliomas
What typen of glioma is most associated to cysts?
Pilocytic astrocytomas (circumscribed astrocytic glioma)
How to differentiate cystic fluid from glioma from CSF
Its usually xanthocromic and clots when removed from the body.
What does “H3 K27M” stand for?
Histone H3 K27M
What does “MGMT” stand for?
methylation O6-methylguanine DNA methyltransferase